PTA球囊导管市场（依材料类型、应用、最终用户和地区）2024-2031

PTA球囊导管市场评估 - 2024-2031

PTA（经皮血管成形术）球囊导管市场受到心血管疾病发病率上升、微创治疗需求增加、球囊导管技术进步以及周边动脉疾病（PAD）治疗意识不断增强的推动，预计将推动市场规模在 2024 年超过 29.8 亿美元，到 2031 年达到约 11.6 亿美元。

市场主要参与企业包括Medtronic、波士顿科学公司、雅培实验室和库克医疗。北美和欧洲凭藉其先进的医疗基础设施成为市场领先地区，而亚太地区预计将因医疗设施的改善和医疗成本的上升而显着增长。受PTA球囊导管需求不断增长的推动，预计2024年至2031年期间市场复合年增长率将达到9.70%。

PTA球囊导管市场定义/概述

PTA（经皮腔内血管成形术）球囊导管是医疗设备。它由一根柔性导管组成，导管尖端有一个小球囊，球囊充气后可将斑块压向血管壁，促进血液循环。

PTA球囊导管用于经经皮血管成形术 (PTA)，以打开狭窄或阻塞的血管（通常是动脉），恢復正常的血流。 PTA对于治疗周边动脉疾病(PAD) 等疾病、改善血液循环以及缓解患肢疼痛和痉挛等症状至关重要。

由于心血管疾病发病率上升、微创手术的进步以及老年人口的增长，预计经皮腔内血管成形术 (PTA) 球囊导管的未来使用将会增加，所有这些都推动了对有效血管干预的需求，以改善患者的治疗效果并缩短恢復时间。

对聚氨酯材料类型的日益增长的偏好是否会推动 PTA 球囊导管市场的成长？

PTA球囊导管中聚氨酯的日益普及预计将推动市场扩张。聚氨酯因其生物相容性、柔韧性和耐用性而广受欢迎，是医疗应用的理想选择。其能贴合各种解剖特征，提高了球囊导管治疗血管疾病的有效性。

此外，聚氨酯具有抗穿刺和抗撕裂的特性，使导管不易断裂，从而提高了患者的安全性和治疗效果。材料科学的进步有望进一步提升聚氨酯导管的性能，从而增加其在医疗产业的应用。这一趋势，加上心血管疾病发生率的上升和对微创手术的需求，预计将显着推动PTA球囊导管市场的发展。

与导管治疗相关的风险和併发症是否会阻碍 PTA 球囊导管市场？

导管治疗相关的风险和危险可能会阻碍PTA球囊导管市场的扩张。感染疾病、血管损伤、血栓症和血管再阻塞都是潜在的併发症，会阻碍患者和医护人员接受这些治疗。此外，安全有效地进行导管治疗需要专业知识，这使得聘请熟练的医护人员变得困难，这可能会阻碍市场的成长。

对恶意事故的担忧可能会导致监管审查力度加大、核准流程更加严格，以及新产品上市延迟。此外，患者对非侵入性治疗的偏好可能会抑制对PTA球囊导管的需求。为了克服这些障碍，持续改善导管设计、改善手术流程并加强病患监测对于确保更安全、更有效的治疗结果并维持市场成长至关重要。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. PTA球囊导管市场（依产品类型）

• 传统球囊导管
• 药物涂层球囊导管
• 药物释放型球囊导管

5. PTA球囊导管市场（依应用）

• 冠状动脉疾病
• 周边动脉疾病
• 肾动脉疾病
• 其他的

6. PTA球囊导管市场（依最终用户）

• 医院
• 门诊手术中心（ASC）
• 专科诊所

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市占率分析

第十章：公司简介

• Medtronic plc
• Terumo Corporation
• Boston Scientific Corporation
• Natec Medical
• Cardinal Health
• Cook Medical
• Biotronik
• Abbott
• Andratec
• Surmodics, Inc.

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

PTA Balloon Catheter Market Valuation - 2024-2031

The PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter Market is being driven by rising cardiovascular disease prevalence, increased demand for minimally invasive procedures, technological advancements in balloon catheters, and growing awareness of peripheral artery disease (PAD) treatments. This is likely to enable the market size surpass USD 2.98 Billion valued in 2024 to reach a valuation of around USD 1.16 Billion by 2031.

Medtronic, Boston Scientific Corporation, Abbott Laboratories and Cook Medical are among the market's leading participants. North America and Europe are the leading regions due to sophisticated healthcare infrastructure, but the Asia-Pacific region is predicted to increase significantly as healthcare facilities improve and healthcare expenditure rises. The rising demand for PTA balloon catheter is enabling the market grow at a CAGR of 9.70% from 2024 to 2031.

PTA Balloon Catheter Market: Definition/ Overview

A PTA (Percutaneous Transluminal Angioplasty) balloon catheter is a medical device used to widen blood arteries that are restricted or occluded. It consists of a flexible catheter with a tiny balloon at the tip that is inflated to compress plaque against the vascular wall, so increasing blood circulation.

PTA balloon catheters are used in percutaneous transluminal angioplasty (PTA) to widen narrowed or obstructed blood vessels, usually arteries, and restore appropriate blood flow. They are critical for treating illnesses such as peripheral artery disease (PAD), increasing circulation, and alleviating symptoms such as pain and cramping in affected limbs.

The future use of PTA (Percutaneous Transluminal Angioplasty) balloon catheters is expected to increase due to rising cardiovascular disease rates, advances in minimally invasive procedures and a growing geriatric population, all of which are driving demand for effective vascular interventions with better patient outcomes and shorter recovery times.

Will Increasing Preference of Polyurethane Material Type Boost the PTA Balloon Catheter Market Growth?

The growing choice for polyurethane in PTA balloon catheters is expected to drive market expansion. Polyurethane is popular because of its high biocompatibility, flexibility, and durability, making it ideal for medical applications. Its capacity to conform to varied anatomical features increases the effectiveness of balloon catheters in treating vascular diseases.

Furthermore, polyurethane's resilience to punctures and tears lowers the likelihood of catheter failure, which improves patient safety and outcomes. As material science advances, polyurethane-based catheters are predicted to function even better, increasing their use in the medical industry. This trend, together with the rising incidence of cardiovascular illnesses and the demand for minimally invasive procedures, will significantly boost the PTA balloon catheter market.

Will Risk and Complication Associated with Catheterization Procedures Hamper the PTA Balloon Catheter Market?

Risks and hazards connected with catheterization operations may impede the expansion of the PTA balloon catheter market. Infections, vascular injury, thrombosis, and restenosis are all potential complications that may prevent patients and healthcare providers from undergoing these treatments. Furthermore, the need for specialized expertise to execute catheterizations safely and successfully may limit the availability of skilled practitioners, weighing on market growth.

Concerns about bad incidents may result in increased regulatory scrutiny and tougher approval processes, thereby delaying the launch of new goods. Furthermore, patients' desire for non-invasive options may diminish demand for PTA balloon catheters. To address these obstacles, continued advances in catheter design, improved procedural procedures, and greater patient monitoring are critical to assuring safer and more effective outcomes, which will sustain market growth.

Category-Wise Acumens

Will Superior Biocompatibility and Flexibility Drive the Polyurethane Segment?

The enhanced biocompatibility and flexibility are key factors boosting the polyurethane segment of the PTA balloon catheter market. Polyurethane's biocompatibility reduces the chance of adverse responses in patients, making it a favoured material for medical equipment. Its suppleness enables the balloon catheter to more successfully negotiate intricate arterial paths, increasing the overall efficacy of the treatment. These qualities not only improve patient safety, but also optimize catheter function during interventions.

Furthermore, polyurethane's resilience and resistance to punctures or tears add to its increasing popularity. As the demand for minimally invasive procedures rises, polyurethane's benefits over other materials are projected to fuel segment dominance, resulting in greater market adoption and innovation in catheter technology.

Will Higher Prevalence and the Need for Frequent Interventions Drive the Application Segment?

The increasing prevalence of coronary artery disease (CAD) and the requirement for frequent interventions will boost the application sector of the PTA balloon catheter market. CAD is a primary cause of cardiovascular events, necessitating the routine use of PTA balloon catheters for angioplasty treatments to restore blood flow and relieve symptoms.

The increasing prevalence of CAD creates a huge demand for effective and dependable treatment alternatives. Furthermore, frequent interventions for CAD patients encourage continued use and improvement in PTA balloon catheter devices. As the population ages and lifestyle-related risk factors increase, the need for these operations is likely to rise. This trend is projected to drive continuous market expansion for PTA balloon catheters, particularly in the coronary artery disease application category. Thus, enabling the segment hold major share in the market growth over the forecast period.

ropel the PTA balloon catheter market in North America. Cardiovascular disorders, such as coronary artery disease and peripheral artery disease, are among the region's most pressing health concerns, necessitating an increase in demand for efficient treatment alternatives. The enormous patient population necessitates frequent interventions, increasing the demand for PTA balloon catheters.

Furthermore, North America's excellent healthcare infrastructure and rapid technological adoption encourage the use of novel medical equipment. The existence of significant medical device manufacturers and robust healthcare policies contribute to market growth. As knowledge of cardiovascular health increases and treatment options expand, the market for PTA balloon catheters in North America is likely to dominate over the forecast period.

Will Improving Healthcare Access in Emerging Economies Drive the Market in Asia Pacific Region?

Increasing healthcare access in emerging economies will drive the Asia-Pacific PTA balloon catheter market. As healthcare infrastructure improves and access to medical services grows, more patients in these economies receive prompt therapies for cardiovascular illnesses. Rising awareness and government measures to improve healthcare delivery contribute to more use of modern medical devices, such as PTA balloon catheters.

Furthermore, the increasing prevalence of cardiovascular disorders in these locations raises the demand for better treatment alternatives. Increased investment in healthcare facilities, combined with the development of low-cost medical gadgets, drives market expansion. As these economies expand their healthcare capacities, Asia-Pacific's PTA balloon catheter market is likely to rise significantly.

Competitive Landscape

The PTA balloon catheter market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the PTA balloon catheter market include:

Medtronic plc

Terumo Corporation

Boston Scientific Corporation

Natec Medical

Cardinal Health

Cook Medical

Biotronik

Abbott

Andratec

Surmodics, Inc.

PTA Balloon Catheter Market Latest Developments

In January 2024, Cook Medical announced that its Slip-Cath Beacon Tip hydrophilic selective catheter is now available in the United States and Canada.

In June 2023, Cook Medical expanded its Advance Serenity hydrophilic percutaneous transluminal angioplasty balloon catheter product line with new sizes and locations.

In March 2023, BrosMed received CE MDR approval for its Tiche 0.035 High-Pressure PTA Balloon Dilatation Catheter. The catheter is intended to treat severe calcified peripheral vascular disease and hard AV cases under the European Medical Device Regulation (MDR).

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. PTA Balloon Catheter Market, By Product Type

• Normal Balloon Catheters
• Drug-Coated Balloon Catheters
• Drug-Eluting Balloon Catheters

5. PTA Balloon Catheter Market, By Application

• Coronary Artery Disease
• Peripheral Artery Disease
• Renal Artery Disease
• Others

6. PTA Balloon Catheter Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• Terumo Corporation
• Boston Scientific Corporation
• Natec Medical
• Cardinal Health
• Cook Medical
• Biotronik
• Abbott
• Andratec
• Surmodics, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References